Results 281 to 290 of about 169,741 (305)

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap, Johann Sebastian de Bono
exaly  

Inflation targeting

1998
Adam S.VE Posen, Thomas Laubach, Frederic S. Mishkin   +2 more
openaire   +3 more sources

Pathophysiological basis of human papillomavirus in penile cancer: Key to prevention and delivery of more effective therapies

Ca-A Cancer Journal for Clinicians, 2016
Adam S Baumgarten, Anna R Giuliano
exaly  

Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine

Nature Reviews Drug Discovery, 2020
Anwesha Dey, Xaralabos Varelas, Kun-Liang Guan   +2 more
exaly  

A blueprint for the primary prevention of cancer: Targeting established, modifiable risk factors

Ca-A Cancer Journal for Clinicians, 2018
Susan M Gapstur, Eric J Jacobs, Lauren R Teras   +2 more
exaly  

Targeting microbial biofilms: current and prospective therapeutic strategies

Nature Reviews Microbiology, 2017
Hyun Koo, Raymond N Allan, Paul Stoodley
exaly  

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

Nature Reviews Drug Discovery, 2009
Jérôme Alexandre, Peng Huang
exaly  

Ribosome-targeting antibiotics and mechanisms of bacterial resistance

Nature Reviews Microbiology, 2013
Daniel N Wilson
exaly  

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

Nature Reviews Clinical Oncology, 2018
Daniel E Johnson, Jennifer R Grandis
exaly  

Turning foes to friends: targeting cancer-associated fibroblasts

Nature Reviews Drug Discovery, 2018
Erwei Song
exaly